Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Clinical trial NCT01982292 · COMPLETED
Trial details
- NCT number
- NCT01982292
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-09-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.